Expansion in Southern Europe


Barcelona - The Italian enterprise Biolab S.p.A. has set up a new Spanish subsidiary at the Parc Científic de Barcelona (PCB, Barcelona Science Park). Called Biolab Española de Análisis e Investigación, this company will provide specialized technical and scientific services aimed at improving the safety, hygiene, efficacy and quality of products and manufacturing processes.
Biolab has a network of laboratories, distributed throughout Italy, with equipment and staff specialized in several fields, such as pharmaceutical chemistry, pharmaceutical microbiology, toxicology, molecular biology, bromatology, alimentary micro-biology and agricultural chemistry.
The company also carries out R&D activities on new analytical and diagnostic methods, new products and manufacturing processes. Research also addresses the development of innovative systems for the control of production lines and product distribution and genetic improvements for the agricultural and stockbreeding sectors.
From its new site at the PCB, Biolab will provide the same services as its Italian mother company and will develop its own research lines in collaboration with the scientific and technical services at the Park. Furthermore, the company wishes to take advantage of the park setting to follow new research lines through possible synergies with the research groups and companies located there.



Granada-based Integromics S.L. has teamed up with the Galician Foundation of Genomic Medicine (FPGMX) in Santiago de Compostela to secure a €1m EU grant from the European Regional Development Fund and the Spanish government. With...



Oryzon Genomics S.A (Barcelona) is entering preclinical testing with a first-in-class bispecific LSD1/MAO-B inhibitor. In addition to the classic target MAO-B, the drug also blocks histone demethylase LSD1, an epigenetic histone...



Granada-based nLife Therapeutics S.L. has raised €5m in total from two venture capitalists. Through Caixa Capital Risc and Caixa Capital Biomed, La Caixa invested €2.5m. The same amount has been placed by Invercaria via its...



Ordesa Laboratories has filed a patent for a novel Bifidobacterium strain isolated from infant feces. It has the capacity to combat rotavirus, says a study (Appl. Environ. Microbiol., doi:10.1128/AEM.05548).



Madrid – Researchers from Spain and the US have discovered an Ebola-like filovirus in bats in northern Spain. The first known filovirus native to Europe was reported in a study published in the journal PLOS Pathogens...



Barcelona - South western Europe gets a new R&D unit in the field of biomolecules. Kymos Pharma, a contract researcher based in Barcelona, has signed an agreement with the French biotechnology group Ipsen to create a R&D group...



Barcelona/Saffron Walden – Almirall S.A. and BioFocus announced that they have entered into a collaboration agreement to identify new compounds against key targets in projects aimed at the treatment of respiratory and...



Madrid/Abu Dhabi – Spanish biotechs are seeking collaborations with firms in the United Arab Emirates. At the end of November, Grupo Zeltia and 14 other Spanish companies presented their research at the forum “Innovation,...



Madrid – The Spanish Minister of Innovation and Science Cristina Garmendia has responded to reports about Roche’s­ delivery stop in Greece and pessimistic expectations for Spain. In Sept­ember, she stressed that the atmosphere...

Displaying results 1 to 10 out of 181

1-10 Next >

© 2007-2015 BIOCOM


All Events


Product of the week


Current issue

All issues